1981
DOI: 10.1016/0002-9378(81)90957-1
|View full text |Cite
|
Sign up to set email alerts
|

Pregnancy-associated plasma protein A: Circulating levels during normal pregnancy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
28
0
1

Year Published

1983
1983
2018
2018

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 102 publications
(31 citation statements)
references
References 10 publications
2
28
0
1
Order By: Relevance
“…Moreover, PAPPA is secreted into the maternal circulation (Folkersen et al 1981), and can be a useful marker for certain diseases and pregnancy complications. For example, unusually low levels of PAPPA in the first trimester may be indicative of increased risk of fetal genetic disorders such as Down's syndrome (Brambati et al 1993) and Cornelia de Lange syndrome (Aitken et al 1999).…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, PAPPA is secreted into the maternal circulation (Folkersen et al 1981), and can be a useful marker for certain diseases and pregnancy complications. For example, unusually low levels of PAPPA in the first trimester may be indicative of increased risk of fetal genetic disorders such as Down's syndrome (Brambati et al 1993) and Cornelia de Lange syndrome (Aitken et al 1999).…”
Section: Introductionmentioning
confidence: 99%
“…The concentration in serum reaches about 50 mg/liter at the end of pregnancy (2,3). PAPP-A was originally characterized as a high molecular weight homotetramer (1,4,5), but it has now been demonstrated that PAPP-A exists in pregnancy serum as a covalent, heterotetrameric 2:2 complex with the proform of eosinophil major basic protein (proMBP), PAPP-A/proMBP (6).…”
mentioning
confidence: 99%
“…During pregnancy, PAPP-A is synthesized and released by the syncytiotrophoblast and maternal serum PAPP-A levels increase throughout pregnancy [15]. PAPP-A is thought to promote growth and development of the placenta by increasing local bioavailability of insulin-like growth factors 1 and 2 (IGF-1 and IGF-2) [16,17].…”
Section: Discussionmentioning
confidence: 99%